1. Home
  2. KBSX vs SKYE Comparison

KBSX vs SKYE Comparison

Compare KBSX & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

N/A

Current Price

$1.24

Market Cap

53.5M

ML Signal

N/A

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.72

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
SKYE
Founded
1976
2012
Country
Taiwan
United States
Employees
394
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
44.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
KBSX
SKYE
Price
$1.24
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$14.75
AVG Volume (30 Days)
12.0K
216.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
86.41
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.68
52 Week High
$6.19
$5.75

Technical Indicators

Market Signals
Indicator
KBSX
SKYE
Relative Strength Index (RSI) 51.59 38.96
Support Level $1.07 $0.68
Resistance Level $1.27 $0.83
Average True Range (ATR) 0.06 0.05
MACD 0.01 0.01
Stochastic Oscillator 58.82 23.49

Price Performance

Historical Comparison
KBSX
SKYE

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: